EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

CpG Methylation‐Driven Pleiotropic Spliced Isoforms of PRSS3 Facilitate Gastric Intratumor Heterogeneity and Metastasis

Mengdi Pang, Hanli Xu, Duoduo Li, Meiying Zhang, Daichuan Chen, Rongmeng Tian, Jie Gu, Nafisa Alimu, EnKai Wang, Ziyun Zhou, Xinyi Li, Qihang Peng und 4 weitere

Cancer Science · 2026

DOI: 10.1111/cas.70227 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2026. Verfasst von Mengdi Pang und 15 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences & Bioengineering, Beijing Jiaotong University, Beijing, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, DNA Methylation, CpG Islands, Serine Endopeptidases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The National Key Research and Development Program of China, National Natural Science Foundation of China, Beijing Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Investigating the phenotypic contribution of gene‐spliced isoforms to tumor cellular heterogeneity can facilitate the development of innovative strategies for precision medicine. Serine protease 3 (PRSS3), a trypsin‐like protease with four spliced variants ( PRSS3‐SVs : PRSS3‐V1 to V4 ), plays diverse biological roles in cancer progression. Herein, we systematically analyzed the expression patterns and functional implications of PRSS3‐SVs in gastric cancer (GC) using an integrative approach that combined bioinformatic analyses, CpG site‐specific methylation detection, splice‐specific qPCR, isoform‐based methodologies, and multiple functional assays. Our findings revealed that differentially expressed PRSS3 isoforms, predominantly PRSS3‐V1 and PRSS3‐V2, are regulated by intragenic methylation and exert pleiotropic roles in GC. Overexpression of PRSS3 transcripts suppressed GC cell proliferation via the NF‐κB signaling pathway, while exerting distinct effects on matrix metalloproteinase‐associated cell migration and invasion. Clinically, patients with low PRSS3‐V1 or high PRSS3‐V2 expression exhibited poorer survival outcomes, and the expression difference between these two transcripts was identified as an independent prognostic indicator for GC patients. Epigenetically, differential methylation patterns within PRSS3 enabled stratification of GC patients into subgroups characterized by either high‐methylation with low‐expressed PRSS3‐SVs or low‐methylation with high‐expressed PRSS3‐SVs . The UHRF1/DNMT1 complex was found to mediate CpG site methylation and regulate PRSS3 transcripts, particularly silencing PRSS3‐V1 through intragenic CpG methylation. This methylation pattern was associated with reduced survival rates and further validated its correlation with tumor metastasis in an independent cohort ( n = 243). Our study elucidates that methylation‐regulated alternative splicing contributes to phenotypic heterogeneity in GC, highlighting its potential advantage over differentially expressed genes in improving stratification strategies for precision oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsDNA MethylationCpG IslandsSerine EndopeptidasesHumansGene Expression Regulation, NeoplasticCell Line, TumorPrognosisCell ProliferationCell MovementAlternative SplicingFemaleMaleNeoplasm MetastasisMiddle AgedEpigenesis, GeneticTrypsin

Stichwörter der Autor:innen

gastric cancerintratumor heterogeneitymethylationserine protease 3 (PRSS3)spliced isoforms

Substanzen

PRSS3 protein, humanSerine EndopeptidasesTrypsin

Autor:innen und Institutionen

  • College of Life Sciences & Bioengineering, Beijing Jiaotong University, Beijing, China.
  • Department of Gastroenterology, Beijing Chest Hospital, Capital Medical University, Beijing, China.
  • Department of Gastroenterology and Hepatology, Chinese PLA General Hospital, Beijing, China.
  • School of Stomatology, Xinjiang Medical University, Urumqi, Xinjiang, China.

ORCID-Profile: Mingzhou Guo, Jiaqiang Huang

Förderung

  • The National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Beijing Natural Science Foundation of China

Zitieren

APA

Pang, M., Xu, H., Li, D., Zhang, M., Chen, D., Tian, R., Gu, J., Alimu, N., Wang, E., Zhou, Z., Li, X., Peng, Q., He, Y., Lin, S., Guo, M., & Huang, J. (2026). CpG Methylation‐Driven Pleiotropic Spliced Isoforms of PRSS3 Facilitate Gastric Intratumor Heterogeneity and Metastasis. Cancer Science. https://doi.org/10.1111/cas.70227

Vancouver

Pang M, Xu H, Li D, Zhang M, Chen D, Tian R, et al. CpG Methylation‐Driven Pleiotropic Spliced Isoforms of PRSS3 Facilitate Gastric Intratumor Heterogeneity and Metastasis. Cancer Science. 2026. doi:10.1111/cas.70227

BibTeX
@article{Pang2026,
  author = {Pang, Mengdi and Xu, Hanli and Li, Duoduo and Zhang, Meiying and Chen, Daichuan and Tian, Rongmeng and Gu, Jie and Alimu, Nafisa and Wang, EnKai and Zhou, Ziyun and Li, Xinyi and Peng, Qihang and He, Yuqi and Lin, Shuye and Guo, Mingzhou and Huang, Jiaqiang},
  title = {CpG Methylation‐Driven Pleiotropic Spliced Isoforms of PRSS3 Facilitate Gastric Intratumor Heterogeneity and Metastasis},
  journal = {Cancer Science},
  year = {2026},
  doi = {10.1111/cas.70227}
}
Kostenlos starten →